首页> 外文OA文献 >Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a retrospective multicenter study

【2h】

Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a retrospective multicenter study

机译：用一线化疗加上抗EGFR或抗VEGF单克隆抗体治疗RAS野生型转移性结肠癌患者的对原发性肿瘤位置的影响：回顾性多中心研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Antonino Grassadonia; Pietro Di Marino; Corrado Ficorella; Alessio Cortellini; Katia Cannita; Alessandro Parisi; Teresa Gamucci; Federica Zoratto; Patrizia Vici; Maddalena Barba; Ettore Porreca; Matteo Neri; Angelo Veronese; Clara Natoli; Michele De Tursi; Nicola Tinari;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a retrospective multicenter study [J] . Antonino Grassadonia, Pietro Di Marino, Corrado Ficorella, Journal of Cancer . 2019,第24期

机译：用一线化疗加上抗EGFR或抗VEGF单克隆抗体治疗RAS野生型转移性结肠癌患者的对原发性肿瘤位置的影响：回顾性多中心研究
2. Impact of Delayed Addition of Anti-EGFR Monoclonal Antibodies on the Outcome of First-Line Therapy in Metastatic Colorectal Cancer Patients: a Retrospective Registry-Based Analysis [J] . Fiala Ondrej, Veskrnova Veronika, Chloupkova Renata, Targeted oncology . 2018,第6期

机译：延迟添加抗EGFR单克隆抗体对转移结直肠癌患者一线治疗结果的影响：基于回顾性的注册表分析
3. Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer [J] . Moretto Roberto, Cremolini Chiara, Rossini Daniele, The oncologist . 2016,第8期

机译：RAS和BRAF野生型转移性结直肠癌患者的原发肿瘤位置和抗表皮生长因子受体单克隆抗体的益处
4. Is High-Dose Chemotherapy Plus Stem-Cell Transplant the Standard Treatment for Patients Failing First-Line Chemotherapy for Metastatic Germ Cell Tumor? [C] . Christian Kollmannsberger, Lawrence Einhorn, Craig Nichols Genitourinary Cancers Symposium. . 2014

机译：高剂量化疗加干细胞移植对转移细胞肿瘤的一线化疗失败的患者的标准治疗吗？
5. Assessing the effectiveness of palliative chemotherapy for non-small cell lung cancer: A phase IV study of patients treated at Ontario's cancer centres [D] . Harrison, Lyndsay Dawn. 2012

机译：评估姑息化疗对非小细胞肺癌的有效性：在安大略省癌症中心接受治疗的患者的IV期研究
6. Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a retrospective multicenter study [O] . Antonino Grassadonia, Pietro Di Marino, Corrado Ficorella, 2019

机译：一线化疗加抗EGFR或抗VEGF单克隆抗体治疗的RAS野生型转移性结肠癌患者原发肿瘤位置的影响：一项回顾性多中心研究
7. Retrospective Study as First-Line Chemotherapy Combined Anti-VEGF Antibody with Fluoropyrimidine for Frail Patients with Unresectable or Metastatic Colorectal Cancer [O] . Motoki Yoshida, Masahiro Goto, Takayuki Kii, 2013

机译：回顾性研究作为一线化疗联合抗VEGF抗体与氟嘧啶的氟嘧啶，用于不可切除或转移结直肠癌

Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a retrospective multicenter study

著录项

引文网络

相似文献

相关主题

期刊订阅